Literature DB >> 17699338

Iranian model of paid and regulated living-unrelated kidney donation.

Ahad J Ghods1, Shekoufeh Savaj.   

Abstract

Since the 1980s, many countries have passed legislation prohibiting monetary compensation for organ donation. Organ donation for transplantation has become altruistic worldwide. During the past two decades, advances in immunosuppressive therapy has led to greater success in transplantation and to increased numbers of patients on transplant waiting lists. Unfortunately, the altruistic supply of organs has been less than adequate, and severe organ shortage has resulted in many patient deaths. A number of transplant experts have been convinced that providing financial incentives to organ sources as an alternative to altruistic organ donation needs careful reconsideration. In 1988, a compensated and regulated living-unrelated donor renal transplant program was adopted in Iran. As a result, the number of renal transplants performed substantially increased such that in 1999, the renal transplant waiting list was completely eliminated. By the end of 2005, a total of 19,609 renal transplants were performed (3421 from living related, 15,356 from living-unrelated and 823 from deceased donors). In this program, many ethical problems that are associated with paid kidney donation also were prevented. Currently, Iran has no renal transplant waiting lists, and >50% of patients with ESRD in the country are living with a functioning graft. In developed countries, the severe shortage of transplantable kidneys has forced the transplant community to adopt new strategies to expand the kidney donor pool. However, compared with the Iranian model, none of these approaches has the potential to eliminate or even alleviate steadily worsening renal transplant waiting lists.

Entities:  

Mesh:

Year:  2006        PMID: 17699338     DOI: 10.2215/CJN.00700206

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  41 in total

1.  Kidneys on demand.

Authors:  Anne Griffin
Journal:  BMJ       Date:  2007-03-10

2.  Compensated living kidney donation: a plea for pragmatism.

Authors:  Faisal Omar; Gunnar Tufveson; Stellan Welin
Journal:  Health Care Anal       Date:  2009-01-29

3.  International survey of nephrologists' perceptions and attitudes about rewards and compensations for kidney donation.

Authors:  Nasrollah Ghahramani; Zahra Karparvar; Mehrdad Ghahramani; Shahrouz Shadrou
Journal:  Nephrol Dial Transplant       Date:  2013-06       Impact factor: 5.992

4.  The organ crisis: a disaster of our own making.

Authors:  T Randolph Beard; Rigmar Osterkamp
Journal:  Eur J Health Econ       Date:  2014-01

Review 5.  Key issues in transplant tourism.

Authors:  Jacob A Akoh
Journal:  World J Transplant       Date:  2012-02-24

6.  The ambiguous lessons of the Iranian model of paid living kidney donation : Fry-Revere, S. (2014). The kidney sellers: a journey of discovery in Iran. (Durham: Carolina Academic Press).

Authors:  Julian J Koplin
Journal:  Monash Bioeth Rev       Date:  2014 Sep-Dec

Review 7.  Paid donation: a global view.

Authors:  Nasrollah Ghahramani; S Adibul Hasan Rizvi; Benita Padilla
Journal:  Adv Chronic Kidney Dis       Date:  2012-07       Impact factor: 3.620

8.  Organ shortage: the greatest challenge facing transplant medicine.

Authors:  David Shafran; Eric Kodish; Andreas Tzakis
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

9.  Attitudes toward strategies to increase organ donation: views of the general public and health professionals.

Authors:  Lianne Barnieh; Scott Klarenbach; John S Gill; Tim Caulfield; Braden Manns
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

Review 10.  Saving lives is more important than abstract moral concerns: financial incentives should be used to increase organ donation.

Authors:  Benjamin Hippen; Lainie Friedman Ross; Robert M Sade
Journal:  Ann Thorac Surg       Date:  2009-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.